Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 SEK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 198,721 More Arrow 238,729 Less Arrow 57,618
Financial expenses 36,017 Less Arrow 18,562 Less Arrow 2,296
Earnings before taxes -253,430 Less Arrow -322,028 More Arrow -168,513
EBITDA -182,844 Less Arrow -300,758 More Arrow -158,776
Total assets 842,429 Less Arrow 653,508 More Arrow 690,515
Current assets 605,898 Less Arrow 461,693 More Arrow 513,524
Current liabilities 537,940 Less Arrow 326,557 Less Arrow 236,569
Equity capital 208,539 Less Arrow 171,335 More Arrow 424,888
- share capital 343,496 Less Arrow 6,683 Less Arrow 6,166
Employees (average) 71 More Arrow 89 Less Arrow 68

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 24.8% More Arrow 26.2% More Arrow 61.5%
Turnover per employee 2,799 Less Arrow 2,682 Less Arrow 847
Profit as a percentage of turnover -127.5% Less Arrow -134.9% Less Arrow -292.5%
Return on assets (ROA) -25.8% Less Arrow -46.4% More Arrow -24.1%
Current ratio 112.6% More Arrow 141.4% More Arrow 217.1%
Return on equity (ROE) -121.5% Less Arrow -188.0% More Arrow -39.7%
Change turnover -40,008 More Arrow 181,111 Less Arrow 57,618
Change turnover % -17% More Arrow 314%
Chg. No. of employees -18 More Arrow 21 Less Arrow 18
Chg. No. of employees % -20% More Arrow 31% More Arrow 36%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.